Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease

Piero Portincasa, Antonio Moschetta, Karel J. van Erpecum, Michele Vacca, Michele Petruzzelli, Giuseppe Calamita, Giuliano Meyer, Giuseppe Palasciano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile, cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into submicroscopic nuclei occurs from these supersaturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.

Original languageEnglish (US)
Pages (from-to)177-184
Number of pages8
JournalCurrent Drug Targets: Immune, Endocrine and Metabolic Disorders
Volume5
Issue number2
DOIs
StatePublished - Jun 2005

Fingerprint

Gallstones
Crystallization
Bile
Cholesterol
Phospholipids
Liquid Crystals
Gallbladder
Bile Acids and Salts
Microscopy
Light

Keywords

  • Bile salts
  • Cholesterol
  • Crystals
  • Gallstone
  • Phospholipids
  • Ursodeoxycholate

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy

Cite this

Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. / Portincasa, Piero; Moschetta, Antonio; van Erpecum, Karel J.; Vacca, Michele; Petruzzelli, Michele; Calamita, Giuseppe; Meyer, Giuliano; Palasciano, Giuseppe.

In: Current Drug Targets: Immune, Endocrine and Metabolic Disorders, Vol. 5, No. 2, 06.2005, p. 177-184.

Research output: Contribution to journalArticle

Portincasa, Piero ; Moschetta, Antonio ; van Erpecum, Karel J. ; Vacca, Michele ; Petruzzelli, Michele ; Calamita, Giuseppe ; Meyer, Giuliano ; Palasciano, Giuseppe. / Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. In: Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 2005 ; Vol. 5, No. 2. pp. 177-184.
@article{8c3a81e6fc7f4bbc9cc9c1ddc67915ee,
title = "Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease",
abstract = "The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile, cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into submicroscopic nuclei occurs from these supersaturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.",
keywords = "Bile salts, Cholesterol, Crystals, Gallstone, Phospholipids, Ursodeoxycholate",
author = "Piero Portincasa and Antonio Moschetta and {van Erpecum}, {Karel J.} and Michele Vacca and Michele Petruzzelli and Giuseppe Calamita and Giuliano Meyer and Giuseppe Palasciano",
year = "2005",
month = "6",
doi = "10.2174/1568008054064922",
language = "English (US)",
volume = "5",
pages = "177--184",
journal = "Endocrine, Metabolic and Immune Disorders - Drug Targets",
issn = "1871-5303",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease

AU - Portincasa, Piero

AU - Moschetta, Antonio

AU - van Erpecum, Karel J.

AU - Vacca, Michele

AU - Petruzzelli, Michele

AU - Calamita, Giuseppe

AU - Meyer, Giuliano

AU - Palasciano, Giuseppe

PY - 2005/6

Y1 - 2005/6

N2 - The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile, cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into submicroscopic nuclei occurs from these supersaturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.

AB - The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile, cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into submicroscopic nuclei occurs from these supersaturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.

KW - Bile salts

KW - Cholesterol

KW - Crystals

KW - Gallstone

KW - Phospholipids

KW - Ursodeoxycholate

UR - http://www.scopus.com/inward/record.url?scp=20044390040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044390040&partnerID=8YFLogxK

U2 - 10.2174/1568008054064922

DO - 10.2174/1568008054064922

M3 - Article

C2 - 16089350

AN - SCOPUS:20044390040

VL - 5

SP - 177

EP - 184

JO - Endocrine, Metabolic and Immune Disorders - Drug Targets

JF - Endocrine, Metabolic and Immune Disorders - Drug Targets

SN - 1871-5303

IS - 2

ER -